Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-11-27 Purchase | 2024-11-27 4:16 pm | AN2 Therapeutics Inc. | ANTX | Zakrzewski Joseph S Director | 2,000 | $1.4 | $2,800 | 531,079 (Indirect Direct) | View |
2024-11-18 Purchase | 2024-11-20 4:11 pm | AN2 Therapeutics Inc. | ANTX | Zakrzewski Joseph S Director | 25,000 | $1.0018 | $25,046 | 529,079 (Indirect Direct) | View |
2024-01-18 Sale | 2024-01-19 7:32 pm | AN2 Therapeutics Inc. | ANTX | Zakrzewski Joseph S Director | 100,000 | $19.11 | $1,911,410 | 504,079 (Indirect Direct) | View |
2022-12-07 Purchase | 2022-12-08 5:09 pm | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 21,202 | $1.3 | $27,563 | 362,340 (Indirect Direct) | View |
2022-05-12 Purchase | 2022-05-16 4:24 pm | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 743 | $1.61 | $1,196 | 341,138 (Indirect Direct) | View |
2022-05-10 Purchase | 2022-05-12 4:35 pm | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 50,406 | $1.8862 | $95,077 | 340,395 (Indirect Direct) | View |
2021-12-23 Purchase | 2021-12-28 6:24 pm | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 1,100 | $9.9052 | $10,896 | 289,989 (Indirect Direct) | View |
2021-12-17 Purchase | 2021-12-21 6:06 pm | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 200 | $9.88 | $1,976 | 288,889 (Indirect Direct) | View |
2021-12-14 Purchase | 2021-12-16 8:01 pm | AMARIN CORP PLC | AMRN | Zakrzewski Joseph S Director | 12,000 | $3.2499 | $38,999 | 196,547 (Direct) | View |
2021-12-15 Purchase | 2021-12-15 8:09 pm | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 3,700 | $10.77 | $39,844 | 288,689 (Indirect Direct) | View |
2021-04-05 Sale | 2021-04-05 8:27 pm | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 10,000 | $140.73 | $1,407,343 | 34,499 (Direct) | View |
2021-04-01 Sale | 2021-04-02 6:08 pm | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 10,000 | $134.64 | $1,346,382 | 44,499 (Direct) | View |
2020-03-17 Purchase | 2020-03-19 5:00 pm | SANGAMO THERAPEUTICS INC | SGMO | Zakrzewski Joseph S Director | 5,000 | $4.99 | $24,950 | 30,000 (Direct) | View |
2020-03-12 Purchase | 2020-03-13 5:41 pm | SANGAMO THERAPEUTICS INC | SGMO | Zakrzewski Joseph S Director | 20,000 | $6.15 | $123,000 | 25,000 (Direct) | View |
2020-01-03 Sale | 2020-01-03 9:30 pm | AMARIN CORP PLC | AMRN | Zakrzewski Joseph S Director | 300,000 | $20.94 | $6,282,870 | 184,547 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-19 Option Award | 2024-06-21 6:12 pm | N/A 2034-06-18 | AN2 Therapeutics Inc. | ANTX | Zakrzewski Joseph S Director | 64,503 | $0 | 64,503 (Direct) | View |
2024-02-06 Exercise | 2024-02-08 4:11 pm | 2024-02-03 2033-02-03 | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 14,150 | $0 | 376,490 (Direct) | View |
2024-02-06 Exercise | 2024-02-08 4:11 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 14,150 | $1.69 | 376,490 (Direct) | View |
2023-06-07 Option Award | 2023-06-09 8:57 pm | N/A 2033-06-06 | AN2 Therapeutics Inc. | ANTX | Zakrzewski Joseph S Director | 23,742 | $0 | 23,742 (Direct) | View |
2023-02-03 Option Award | 2023-02-07 4:48 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 14,150 | $0 | 14,150 (Direct) | View |
2022-05-12 Option Award | 2022-05-16 9:11 pm | N/A 2032-05-11 | AN2 Therapeutics Inc. | ANTX | Zakrzewski Joseph S Director | 10,362 | $0 | 10,362 (Direct) | View |
2022-03-29 Conversion | 2022-03-31 8:15 pm | N/A N/A | AN2 Therapeutics Inc. | ANTX | Zakrzewski Joseph S Director | 98,199 | $0 | 98,199 (Direct) | View |
Ownership | 2022-03-24 9:26 pm | N/A N/A | AN2 Therapeutics Inc. | ANTX | Zakrzewski Joseph S Director | 0 | $0 | 704,078 (Indirect) | View |
2022-02-25 Option Award | 2022-03-01 5:15 pm | N/A 2032-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Zakrzewski Joseph S Director | 37,500 | $0 | 85,700 (Direct) | View |
2022-02-22 Option Award | 2022-02-24 5:03 pm | N/A 2032-02-22 | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 14,150 | $0 | 14,150 (Direct) | View |
2021-11-19 Disposition | 2021-11-22 09:12 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 53,907 | $0 | 0 (Direct) | View |
2021-11-19 Equity Swap | 2021-11-22 09:12 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 34,499 | $0 | 0 (Direct) | View |
2021-06-22 Conversion | 2021-06-24 8:54 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 258,671 | $0 | 284,989 (Indirect) | View |
Ownership | 2021-06-17 9:43 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 0 | $0 | 382,198 (Direct) | View |
2021-06-14 Option Award | 2021-06-16 8:07 pm | N/A 2031-06-14 | AMARIN CORP PLC | AMRN | Zakrzewski Joseph S Director | 81,953 | $0 | 81,953 (Direct) | View |
2021-04-05 Exercise | 2021-04-05 8:27 pm | N/A 2023-12-05 | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 10,000 | $0 | 34,499 (Direct) | View |
2021-04-05 Exercise | 2021-04-05 8:27 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 10,000 | $24.11 | 34,499 (Direct) | View |
2021-04-01 Exercise | 2021-04-02 6:08 pm | N/A 2023-12-05 | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 10,000 | $0 | 44,499 (Direct) | View |
2021-04-01 Exercise | 2021-04-02 6:08 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 10,000 | $24.11 | 44,499 (Direct) | View |
2021-02-25 Option Award | 2021-03-01 9:07 pm | N/A 2031-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Zakrzewski Joseph S Director | 24,600 | $0 | 64,600 (Direct) | View |
2021-01-29 Option Award | 2021-02-02 7:00 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 4,844 | $0 | 37,721 (Direct) | View |
2020-10-21 Exercise | 2020-10-22 8:03 pm | N/A 2020-11-11 | AMARIN CORP PLC | AMRN | Zakrzewski Joseph S Director | 100,000 | $0 | 184,547 (Direct) | View |
2020-10-21 Exercise | 2020-10-22 8:03 pm | N/A N/A | AMARIN CORP PLC | AMRN | Zakrzewski Joseph S Director | 100,000 | $3.4 | 184,547 (Direct) | View |
2020-07-13 Option Award | 2020-07-15 8:09 pm | N/A 2030-07-13 | AMARIN CORP PLC | AMRN | Zakrzewski Joseph S Director | 61,996 | $0 | 61,996 (Direct) | View |
2020-05-18 Option Award(A) | 2020-06-03 4:30 pm | N/A 2030-05-17 | SANGAMO THERAPEUTICS INC | SGMO | Zakrzewski Joseph S Director | 30,000 | $0 | 60,000 (Direct) | View |
2020-05-18 Option Award | 2020-05-20 5:22 pm | N/A 2030-05-17 | SANGAMO THERAPEUTICS INC | SGMO | Zakrzewski Joseph S Director | 17,500 | $0 | 47,500 (Direct) | View |
2020-01-22 Option Award | 2020-01-24 5:59 pm | N/A 2030-01-22 | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 9,562 | $0 | 41,062 (Direct) | View |
2020-01-07 Exercise | 2020-01-09 4:36 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 18,750 | $3.88 | 31,500 (Direct) | View |
2020-01-07 Exercise | 2020-01-09 4:36 pm | N/A 2021-03-10 | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 18,750 | $0 | 31,500 (Direct) | View |
2020-01-03 Exercise | 2020-01-03 9:30 pm | N/A 2020-11-11 | AMARIN CORP PLC | AMRN | Zakrzewski Joseph S Director | 300,000 | $0 | 184,547 (Direct) | View |
2020-01-03 Exercise | 2020-01-03 9:30 pm | N/A N/A | AMARIN CORP PLC | AMRN | Zakrzewski Joseph S Director | 300,000 | $3.4 | 184,547 (Direct) | View |